COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,962 Articles (22,604 medRxiv, 8,358 bioRxiv)

Most recent first Previous |  Page 3088: Articles 30871-30880  | Next

Transmission Dynamics of 2019-nCoV in Malaysia
Labadin, J., Hong, B. H.
10.1101/2020.02.07.20021188 — Posted: 2020-02-11
Diarrhea may be underestimated: a missing link in 2019 novel coronavirus
Liang, W., Rao, S., Xiao, C., Lin, Z., Zhang, Q., Qi, W.
10.1101/2020.02.03.20020289 — Posted: 2020-02-11 Discussion: Onsite
Estimation of the asymptomatic ratio of novel coronavirus (2019-nCoV) infections among passengers on evacuation flights
Nishiura, H., Kobayashi, T., Miyama, T., Suzuki, A., Jung, S., Hayashi, K., Kinoshita, R., Yang, Y., Yuan, B., Akhmetzhanov, A. R., Linton, N. M.
10.1101/2020.02.03.20020248 — Posted: 2020-02-11
Networks of information token recurrences derived from genomic sequences may reveal hidden patterns in epidemic outbreaks: A case study of the 2019-nCoV coronavirus.
Luczak-Roesch, M.
10.1101/2020.02.07.20021139 — Posted: 2020-02-11
The Novel Coronavirus, 2019-nCoV, is Highly Contagious and More Infectious Than Initially Estimated
Sanche, S., Lin, Y. T., Xu, C., Romero-Severson, E., Hengartner, N., Ke, R.
10.1101/2020.02.07.20021154 — Posted: 2020-02-11 Discussion: Onsite
Tracking the spread of novel coronavirus (2019-nCoV) based on big data
Zhao, X., Liu, X., Li, X.
10.1101/2020.02.07.20021196 — Posted: 2020-02-11 Discussion: Onsite
Tobacco-use disparity in gene expression of ACE2, the receptor of 2019-nCov
Cai, G.
10.1101/2020.02.05.20020107 — Posted: 2020-02-11
The transmembrane serine protease inhibitors are potential antiviral drugs for 2019-nCoV targeting the insertion sequence-induced viral infectivity enhancement
Meng, T., Cao, H., Zhang, H., Kang, Z., Xu, D., Gong, H., Wang, J., Li, Z., Cui, X., Xu, H., Wei, H., Pan, X., Zhu, R., Xiao, J., Zhou, W., Cheng, L., Liu, J.
10.1101/2020.02.08.926006 — Posted: 2020-02-11 Discussion: Onsite
The Essential Facts of Wuhan Novel Coronavirus Outbreak in China and Epitope-based Vaccine Designing against 2019-nCoV
Sarkar, B., Ullah, M. A., Johora, F. T., Taniya, M. A., Araf, Y.
10.1101/2020.02.05.935072 — Posted: 2020-02-11
Design of multi epitope-based peptide vaccine against E protein of human 2019-nCoV: An immunoinformatics approach
Abdelmageed, M. I., Abdelmoneim, A. H., Mustafa, M. I., Elfadol, N. M., Murshed, N. S., Shantier, S. W., Makhawi, A. M.
10.1101/2020.02.04.934232 — Posted: 2020-02-11 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).